Technical Analysis for AST - Asterias Biotherapeutics, Inc.

Grade Last Price % Change Price Change
grade C 0.945 -0.53% -0.01
AST closed down 0.53 percent on Thursday, March 7, 2019, on 53 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical AST trend table...

Date Alert Name Type % Chg
Mar 7 20 DMA Support Bullish 0.00%
Mar 7 Bollinger Band Squeeze Range Contraction 0.00%
Mar 7 Inside Day Range Contraction 0.00%
Mar 6 Crossed Above 20 DMA Bullish -0.53%
Mar 6 Bollinger Band Squeeze Range Contraction -0.53%
Mar 5 Hammer Candlestick Bullish 6.18%
Mar 5 Lizard Bullish Bullish Day Trade Setup 6.18%
Mar 5 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 6.18%
Mar 5 Bollinger Band Squeeze Range Contraction 6.18%
Mar 4 Fell Below 20 DMA Bearish 8.62%

Older signals for AST ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Asterias Biotherapeutics, Inc., a development stage biotechnology company, focuses on the development of therapeutic products to treat neurology, oncology, cardiology, metabolic diseases, ophthalmology, orthopedics, and blood and vascular diseases. It is also developing human embryonic stem cell programs, including cell lines and a Phase I clinical trial in patients with acute spinal cord injury; intellectual property related to its autologous cellular immunotherapy program, including a Phase I/II clinical trial of autologous immunotherapy in patients with acute myelogenous leukemia; and non-therapeutic applications of pluripotent stem cells, such as cellular assay products for use in drug development and toxicity screening. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is based in Menlo Park, California.
Biotechnology Biology Nature Immunotherapy Stem Cells Drug Development Therapeutic Products Metabolic Diseases Biotime Embryonic Stem Cell Vascular Diseases Oxycyte
Is AST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.05
52 Week Low 0.51
Average Volume 159,388
200-Day Moving Average 1.2485
50-Day Moving Average 0.824
20-Day Moving Average 0.9123
10-Day Moving Average 0.9335
Average True Range 0.0736
ADX 22.86
+DI 22.2222
-DI 14.9927
Chandelier Exit (Long, 3 ATRs ) 0.7792
Chandelier Exit (Short, 3 ATRs ) 1.0208
Upper Bollinger Band 0.9944
Lower Bollinger Band 0.8302
Percent B (%b) 0.7
BandWidth 17.998465
MACD Line 0.0215
MACD Signal Line 0.025
MACD Histogram -0.0036
Fundamentals Value
Market Cap 47.23 Million
Num Shares 50 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -1.26
Price-to-Sales 20.30
Price-to-Book 3.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.02
Resistance 3 (R3) 1.01 0.98 1.01
Resistance 2 (R2) 0.98 0.96 0.98 1.00
Resistance 1 (R1) 0.96 0.95 0.97 0.97 1.00
Pivot Point 0.93 0.93 0.94 0.93 0.93
Support 1 (S1) 0.91 0.91 0.92 0.92 0.89
Support 2 (S2) 0.88 0.90 0.89 0.89
Support 3 (S3) 0.87 0.88 0.89
Support 4 (S4) 0.87